Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gebhard

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
IJTLD Open|May 14, 2025
Treatment success rate and time to culture conversion under a prospective BPaL cohort studyE Burhan, J Sugiharto, M Soemarno, et al.
Plos One|November 19, 2024
Introducing BPaL: Experiences from countries supported under the LIFT-TB projectD F Wares, M Mbenga, V Mirtskhulava, et al.
IJTLD Open|April 17, 2026
High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the PhilippinesI Flores, M A A Tujan, R Basilio, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
The European Respiratory Journal|August 11, 2011
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateD Falzon, E Jaramillo, H J Schünemann, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
IJTLD Open|May 14, 2025
Treatment success rate and time to culture conversion under a prospective BPaL cohort studyE Burhan, J Sugiharto, M Soemarno, et al.
Plos One|November 19, 2024
Introducing BPaL: Experiences from countries supported under the LIFT-TB projectD F Wares, M Mbenga, V Mirtskhulava, et al.
IJTLD Open|April 17, 2026
High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the PhilippinesI Flores, M A A Tujan, R Basilio, et al.
BMC Public Health|July 17, 2021
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patientsS E J van de Berg, P T Pelzer, A J van der Land, et al.
The European Respiratory Journal|August 11, 2011
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateD Falzon, E Jaramillo, H J Schünemann, et al.
Pageof 3